This company is a small, early-stage nutritional and regenerative medicine company developing natural supplement products. Its core product focus includes stem cell mobilizing agents — natural, patent-pending formulations designed to help individuals mobilize their own adult stem cells from bone marrow — as well as an all-natural diet aid designed to suppress hunger through normal body signals. The company is also researching secretogues, which are compounds that stimulate the body's own growth hormone production, and other natural bioactive formulations aimed at enhancing human performance. The company plans to sell its products through private-label arrangements, meaning other companies would market and sell the products under their own brands. The company currently has no described revenue-generating operations, manufacturing infrastructure, or established distribution channels, and appears to be pre-revenue. The company recently underwent a leadership change and is in the process of reshaping its strategy.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →